Advice To Scientist-Writers: Beware Old 'Fallacies'

[Ed. note: H.J. Tichy, professor emerita in English at the City University of New York and a special- ist in technical and scientific writing, pities the poor scientist who, from time to time, must turn reluctantly away from his or her experiments in order to write—and who finds the task of writing well to be painful and unrewarding. Why don’t scientists take more pleasure from writing up their lab reports, their grant proposals, their journal articles? And why aren’t they bett

Written byHj Tichy
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

[Ed. note: H.J. Tichy, professor emerita in English at the City University of New York and a special- ist in technical and scientific writing, pities the poor scientist who, from time to time, must turn reluctantly away from his or her experiments in order to write—and who finds the task of writing well to be painful and unrewarding. Why don’t scientists take more pleasure from writing up their lab reports, their grant proposals, their journal articles? And why aren’t they better at it? Tichy, who has worked as a writing consultant for such clients as the American Chemical Society, SmithKline Beckman, and Monsanto, lays much of the blame at the feet of old-fashioned pedagogues who have cluttered the minds and inhibited the creative expression of scientist writers with a horde of debilitating, constraining, and plain dumb "rules for good writing.” She calls these rules “fallacies,” and in this article, (John ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies